These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 25348761)
1. Mucocutaneous manifestations of inflammatory bowel disease in Turkey. Topaloğlu Demir F; Kocatürk E; Yorulmaz E; Adalı G; Kavala M J Cutan Med Surg; 2014 Nov; 18(6):397-404. PubMed ID: 25348761 [TBL] [Abstract][Full Text] [Related]
2. Mucocutaneous manifestations in inflammatory bowel disease. Yüksel I; Başar O; Ataseven H; Ertuğrul I; Arhan M; Ibiş M; Dağli U; Demirel BT; Ulker A; Seçilmiş S; Saşmaz N Inflamm Bowel Dis; 2009 Apr; 15(4):546-50. PubMed ID: 19023896 [TBL] [Abstract][Full Text] [Related]
3. Mucocutaneous manifestations of inflammatory bowel disease in central China -a single-centre study. Kou CX; Zhang YY; Li GW; Li J; Kong QT; Chen J; Liu F; Zhang M; Wang FY; Jiang Y; Hao LY; Ren JA; Sang H J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):e211-e212. PubMed ID: 29194792 [No Abstract] [Full Text] [Related]
4. Dermatologic manifestations in inflammatory bowel disease in Tunisia. Mebazaa A; Aounallah A; Naija N; Cheikh Rouhou R; Kallel L; El Euch D; Boubaker J; Mokni M; Filali A; Ben Osman A Tunis Med; 2012 Mar; 90(3):252-7. PubMed ID: 22481199 [TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of cutaneous manifestations and related factors in patients with ulcerative colitis]. Tian Y; Li JX; Wang HH; Li RY; Liu XG Zhonghua Nei Ke Za Zhi; 2016 Jul; 55(7):505-9. PubMed ID: 27373283 [TBL] [Abstract][Full Text] [Related]
6. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. Ampuero J; Rojas-Feria M; Castro-Fernández M; Cano C; Romero-Gómez M J Gastroenterol Hepatol; 2014 Feb; 29(2):291-5. PubMed ID: 23927379 [TBL] [Abstract][Full Text] [Related]
7. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Bandyopadhyay D; Bandyopadhyay S; Ghosh P; De A; Bhattacharya A; Dhali GK; Das K Indian J Gastroenterol; 2015 Sep; 34(5):387-94. PubMed ID: 26614005 [TBL] [Abstract][Full Text] [Related]
8. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. Veloso FT; Carvalho J; Magro F J Clin Gastroenterol; 1996 Jul; 23(1):29-34. PubMed ID: 8835896 [TBL] [Abstract][Full Text] [Related]
9. [Cutaneous involvement in chronic inflammatory bowel disease : Crohn's disease and ulcerative colitis]. Richter L; Rappersberger K Hautarzt; 2016 Dec; 67(12):940-947. PubMed ID: 27830291 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations in inflammatory bowel disease. Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504 [TBL] [Abstract][Full Text] [Related]
11. [Cutaneous manifestations in inflammatory bowel disease]. Chavez-Álvarez S; Gómez-Flores M; Ocampo-Candiani J Gac Med Mex; 2016; 152(5):622-630. PubMed ID: 27792697 [TBL] [Abstract][Full Text] [Related]
12. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Farhi D; Cosnes J; Zizi N; Chosidow O; Seksik P; Beaugerie L; Aractingi S; Khosrotehrani K Medicine (Baltimore); 2008 Sep; 87(5):281-293. PubMed ID: 18794711 [TBL] [Abstract][Full Text] [Related]
13. Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study. Moravvej H; Razavi GM; Farshchian M; Malekzadeh R Indian J Dermatol Venereol Leprol; 2008; 74(6):607-10. PubMed ID: 19171983 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Kilic Y; Kamal S; Jaffar F; Sriranganathan D; Quraishi MN; Segal JP Inflamm Bowel Dis; 2024 Feb; 30(2):230-239. PubMed ID: 37042969 [TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease. Menachem Y; Gotsman I Isr Med Assoc J; 2004 Feb; 6(2):88-90. PubMed ID: 14986464 [TBL] [Abstract][Full Text] [Related]
16. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease. Goldberg I; Finkel O; Gat A; Sprecher E; de Morentin HM Isr Med Assoc J; 2014 Mar; 16(3):168-70. PubMed ID: 24761705 [TBL] [Abstract][Full Text] [Related]
17. Extraintestinal Manifestations in Vedolizumab and Anti-TNF-Treated Patients With Inflammatory Bowel Disease. Dubinsky MC; Cross RK; Sandborn WJ; Long M; Song X; Shi N; Ding Y; Eichner S; Pappalardo B; Ganguli A; Wang A Inflamm Bowel Dis; 2018 Aug; 24(9):1876-1882. PubMed ID: 29668916 [TBL] [Abstract][Full Text] [Related]
18. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study]. Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523 [TBL] [Abstract][Full Text] [Related]
20. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. Zippi M; Corrado C; Pica R; Avallone EV; Cassieri C; De Nitto D; Paoluzi P; Vernia P World J Gastroenterol; 2014 Dec; 20(46):17463-7. PubMed ID: 25516659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]